Treace Announces First Surgical Cases with SuperBite Compression Screw System

Treace Medical Concepts, a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first cases utilising its SuperBite Compression Screw System.

SuperBite screws are engineered to deliver advanced compression through a variable thread pitch and optimised headless design, with their self-drilling and countersinking features enabling rapid screw insertion. The screw implants also incorporate a bevelled head design with smoothed edges, making them ideal for both minimally invasive and traditional open surgical approaches. The SuperBite system offers comprehensive screw diameters ranging from 2.5mm to 7.0mm to address a broad range of foot & ankle surgical applications across the forefoot, midfoot, and hindfoot.

Anne Holly Johnson, MD, of Hospital for Special Surgery (New York, New York) and a member of Treace’s Surgeon Advisory Board, performed the first cases with the new SuperBite screws. She commented, “My first cases with the SuperBite screws were very successful. I was impressed with the streamlined insertion and great compression. Compression screws are the most common fixation used in foot and ankle surgery, and I plan to use the SuperBite screws in many different fusion and osteotomy applications.”

“The launch of SuperBite represents an important milestone in the expansion of our market-leading bunion & midfoot technology portfolio,” said John T. Treace, CEO and Chairman of Treace. “SuperBite allows our direct sales team to more fully service our 3,300+ surgeon customers technology needs, not only in the procedures they perform with us today, but also a significant volume of incremental procedures throughout the foot and ankle where compression screws are utilised.   We believe SuperBite screws will expand our addressable market, accelerate our case volumes, and grow our customer share of wallet, all while further advancing our position as a 1-stop-shop for our customers.”

Full commercialisation of the SuperBite Compression Screw System is anticipated in the third quarter of 2026. Along with its other expected 2026 product launch, the SpeedXM Midfoot Fusion System, the two products are expected to increase Treace’s total addressable market by an estimated $300 million.